Thursday, July 9, 2026

pharma · GYRE

GYRE THERAPEUTICS

GYRE THERAPEUTICS drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

SAN DIEGO, CA, USA HQ
Public company Type
GYRE · NYSE Ticker
Company details
Status
Public
HQ
SAN DIEGO, CA, USA
Programs
0
Drugs
0
Patents
0
Intelligence · Drug Pipeline

GYRE THERAPEUTICS pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

GYRE THERAPEUTICS drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →